| 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0100 | 0.1200 | -108.33 | 0.2200 | | 每股净资产（元） | 10.49 | 10.86 | -3.41 | 10.63 | | 每股公积金(元) | 5.37 | 5.38 | -0.19 | 5.45 | | 每股未分配利润(元) | 3.60 | 4.00 | -10 | 3.75 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.49 | 1.17 | -58.12 | 1.75 | | 净利润(亿元) | -0.01 | 0.22 | -104.55 | 0.4 | | 净资产收益率(%) | -0.07 | 1.12 | -106.25 | 2.06 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 三、分红送配方案情况 本次公司不分配不转赠。 前十大流通股东 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.1100 | -0.0900 | -22.22 | -0.1100 | | 每股净资产（元） | 1.86 | 2.39 | -22.18 | 3.08 | | 每股公积金(元) | 1.63 | 1.64 | -0.61 | 1.64 | | 每股未分配利润(元) | -1.18 | -0.68 | -73.53 | 0.0057 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.62 | 3.57 | 1.4 | 2.99 | | 净利润(亿元) | -0.73 | -0.64 | -14.06 | -0.72 | | 净资产收益率(%) | -5.57 | -3.86 | -44.3 | -3.39 | 三、分红送配方案情况 本次公司不分配不转赠。 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0223 | 0.0034 | 555.88 | 0.0916 | | 每股净资产（元） | 0 | 2.08 | -100 | 3.16 | | 每股公积金(元) | 1.2 | 0 | 0 | 1.19 | | 每股未分配利润(元) | 0.92 | 0.69 | 33.33 | 0.31 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.66 | 1.22 | -45.9 | 1.3 | | 净利润(亿元) | 0.11 | 0.02 | 450 | 0.44 | | 净资产收益率(%) | | 0.11 | -100 | 2.95 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 29433.78万股，累计占流通股比： 60.7%，较上期变化： 125.42万股。 本次公司 ...

Financial Performance - The company reported a basic earnings per share of -0.0089 yuan for Q1 2025, an improvement of 22.61% compared to -0.0115 yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.18 billion yuan, showing a 21.74% increase from -0.23 billion yuan in Q1 2024 [1] - Operating revenue increased by 8.46% to 1.41 billion yuan in Q1 2025, compared to 1.3 billion yuan in Q1 2024 [1] - The return on equity was -1.02% in Q1 2025, slightly worse than -0.94% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 83,827.98 million shares, accounting for 50.22% of the circulating shares, with a decrease of 17.45 million shares from the previous period [1] - Shenzhen Landi Technology Development Co., Ltd. remains the largest shareholder with 21,877.26 million shares, representing 13.11% of total share capital [2] - New entrant in the top ten shareholders is Li Songqiang, holding 1,543.61 million shares, which is 0.92% of total share capital [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in this period [3]

Core Viewpoint - The company, Northeast Pharmaceutical Group Co., Ltd., has disclosed its quarterly report, ensuring the accuracy and completeness of the financial information presented, and has not undergone an audit for this report [1][2][13]. Financial Data Summary - The company reported a significant increase in other current assets, with a year-end balance of 34.68 million yuan, reflecting a 31% growth compared to the beginning of the year, primarily due to changes in tax payments [4]. - The balance of notes payable decreased to 2.05 billion yuan, a reduction of 42% from the beginning of the year, attributed to a decrease in issued notes [5]. - The payable to employees dropped to 2.62 million yuan, down 94% from the beginning of the year, due to a reduction in employee compensation [5]. - The balance of taxes payable was 54.97 million yuan, a decrease of 31% from the beginning of the year, influenced by tax payments made during the period [5]. - Research and development expenses amounted to 32 million yuan, an increase of 88% year-on-year, indicating a higher investment in R&D [5]. - Financial expenses were reported at -7.68 million yuan, a decrease of 32% year-on-year, due to reduced interest expenses on bank loans [5]. - Investment income was 1.35 million yuan, down 41% year-on-year, primarily due to a decrease in debt restructuring amounts [5]. - The company reported a significant reduction in credit impairment losses, amounting to -5.87 million yuan, a decrease of 2380% year-on-year, due to an increase in accounts receivable [5]. - The asset impairment loss was -64.44 million yuan, a decrease of 71% year-on-year, attributed to an increase in inventory write-down provisions [5]. - The company recorded a net cash inflow from the disposal of fixed assets of 30,000 yuan, a decrease of 92% year-on-year, indicating reduced cash recovery from asset disposals [8]. - Cash received from bank borrowings was 14.4 billion yuan, an increase of 157% year-on-year, reflecting higher bank loan receipts [9]. - Cash paid for debt repayment was 9.92 billion yuan, an increase of 183% year-on-year, due to increased cash outflows for loan repayments [9]. Legal Matters - The company is involved in a legal dispute with a claim for economic damages of 32.7 million yuan and additional interest losses of approximately 25.15 million yuan, totaling 57.85 million yuan [15][16]. - The case has been accepted by the court and is scheduled for a hearing on May 12, 2025 [17]. - The company has stated that there are no other undisclosed significant litigation or arbitration matters as of the announcement date [18].

Core Insights - German American Bancorp (GABC) reported a revenue of $81.41 million for Q1 2025, marking a year-over-year increase of 33.9% and exceeding the Zacks Consensus Estimate of $79.1 million by 2.92% [1] - The company's EPS for the same quarter was $0.79, up from $0.64 a year ago, representing a surprise of 9.72% compared to the consensus estimate of $0.72 [1] Financial Performance Metrics - Efficiency ratio was reported at 61.3%, higher than the estimated 56.3% by analysts [4] - Net Interest Margin stood at 4%, surpassing the average estimate of 3.7% [4] - Net charge-offs to average loans were 0%, compared to the estimated 0.1% [4] - Total Average Interest Earning Assets reached $6.92 billion, exceeding the estimate of $6.85 billion [4] - Net Gains on Sales of Loan were $0.83 million, slightly below the estimated $0.90 million [4] - Total Non-interest Income was reported at $14.84 million, lower than the estimated $15.95 million [4] - Net interest income (FTE) was $67.89 million, compared to the average estimate of $62.41 million [4] - Service charges on deposit accounts were $3.49 million, below the estimated $3.81 million [4] - Net Interest Income was reported at $66.57 million, exceeding the estimate of $63.51 million [4] Stock Performance - Shares of German American Bancorp have returned -3.1% over the past month, outperforming the Zacks S&P 500 composite's -4.3% change [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [3]

Financial Performance - HomeStreet (HMST) reported revenue of $45.36 million for the quarter ended March 2025, marking a year-over-year increase of 9% [1] - The EPS for the same period was -$0.15, an improvement from -$0.29 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $44.39 million, resulting in a surprise of +2.19% [1] - The company experienced an EPS surprise of -114.29%, with the consensus EPS estimate being -$0.07 [1] Key Metrics - Net Interest Margin was reported at 1.8%, slightly below the estimated 1.9% [4] - Efficiency Ratio was 102.9%, higher than the estimated 101.2% [4] - Net Interest Income was $33.22 million, compared to the average estimate of $35.94 million [4] - Net gain on loan origination and sale activities was $3.22 million, exceeding the estimated $2.09 million [4] - Total noninterest income reached $12.14 million, significantly above the average estimate of $9.36 million [4] Stock Performance - HomeStreet shares have returned +20.1% over the past month, contrasting with the Zacks S&P 500 composite's -4.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Legget & Platt reported revenue of $1.02 billion for the quarter ended March 2025, reflecting a 6.8% decline year-over-year and a slight miss of 0.53% against the Zacks Consensus Estimate of $1.03 billion [1] - The company's EPS was $0.24, which is an increase from $0.23 in the same quarter last year, resulting in a positive surprise of 4.35% compared to the consensus estimate of $0.23 [1] Revenue and Earnings Performance - The change in organic sales for Bedding Products was -12%, significantly worse than the estimated -4% [4] - Specialized Products saw a -5% change in organic sales, compared to an average estimate of -3.1% [4] - Furniture, Flooring, and Textile Products experienced a -1% change in organic sales, better than the estimated -5.4% [4] - Overall change in organic sales was -7%, against an estimate of -5.6% [4] Trade Sales and EBIT Analysis - Trade sales for Furniture, Flooring, and Textile Products were reported at $331.30 million, exceeding the average estimate of $322.63 million, with a year-over-year change of -0.5% [4] - Trade sales for Specialized Products were $300.10 million, slightly above the average estimate of $298.78 million, reflecting a -5% year-over-year change [4] - Trade sales for Bedding Products were $390.70 million, below the average estimate of $409.90 million, indicating a -12.8% year-over-year decline [4] - EBIT for Bedding Products was $9.60 million, significantly lower than the average estimate of $18.65 million [4] - EBIT for Specialized Products was $28.40 million, surpassing the average estimate of $20.42 million [4] - Adjusted EBIT for Specialized Products was $31.80 million, exceeding the average estimate of $23 million [4] - Adjusted EBIT for Bedding Products was $13 million, below the average estimate of $16.45 million [4] - Adjusted EBIT for Furniture, Flooring, and Textile Products was $21.70 million, above the average estimate of $18.90 million [4] Stock Performance - Legget & Platt's shares have returned -8.7% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Enterprise Financial Services (EFSC) reported a revenue of $166 million for the quarter ended March 2025, reflecting a year-over-year increase of 10.8% [1] - The earnings per share (EPS) for the quarter was $1.31, up from $1.07 in the same quarter last year, surpassing the consensus EPS estimate of $1.17 by 11.97% [1] - The reported revenue exceeded the Zacks Consensus Estimate of $160.06 million, resulting in a revenue surprise of 3.71% [1] Financial Performance Metrics - Efficiency Ratio stood at 60.1%, better than the average estimate of 61.1% from three analysts [4] - Net Interest Margin was reported at 4.2%, slightly above the average estimate of 4.1% from three analysts [4] - Total nonperforming loans amounted to $109.88 million, significantly higher than the average estimate of $44.79 million from two analysts [4] - Average Balance of Total Interest Earning Assets was $14.65 billion, exceeding the average estimate of $14.57 billion from two analysts [4] - Net charge-offs to average loans were reported at 0%, better than the average estimate of 0.2% from two analysts [4] - Total Noninterest Income reached $18.48 million, surpassing the average estimate of $16.04 million from three analysts [4] - Net Interest Income was reported at $147.52 million, above the average estimate of $144 million from two analysts [4] - Deposit service charges totaled $4.42 million, slightly higher than the average estimate of $4.37 million from two analysts [4] - Tax credit income was $2.61 million, exceeding the average estimate of $1.75 million from two analysts [4] - Net interest income (FTE) was reported at $149.99 million, compared to the average estimate of $146.43 million from two analysts [4] - Wealth management income was $2.66 million, below the average estimate of $2.87 million from two analysts [4] Stock Performance - Shares of Enterprise Financial Services have returned -4.7% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]